LB

Lawrence Bloch

North America, Massachusetts, United States, Cambridge

Description

Lawrence Bloch, M.D., J.D. is the former President of Infinity. He joined the company as chief financial officer and chief business officer ...

Investor Profile

Lawrence Bloch has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Debt Financing (50%)
  • Series B (50%)

Country Focus

  • Canada (100%)

Industry Focus

  • Biotechnology
  • Neuroscience
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Lawrence Bloch frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
H.I.G. Capital
North America, Florida, United States, Miami
Co-Investments: 2
Ventures West
North America, British Columbia, Canada, Vancouver
Co-Investments: 2
The Ontario Capital Growth
North America, Ontario, Canada, Toronto
Co-Investments: 1
BDC Venture Capital
North America, Alberta, Canada, Calgary
Co-Investments: 2
Genesys Capital
North America, Ontario, Canada, Toronto
Co-Investments: 1
N
North America, Virginia, United States, Charlottesville
Co-Investments: 2
CTI Life Sciences Fund
North America, Quebec, Canada, Montréal
Co-Investments: 1
Delphi Ventures
North America, California, United States, San Mateo
Co-Investments: 2

What are some of recent deals done by Lawrence Bloch?

NeurAxon

Toronto, Ontario, Canada

NeurAxon discovers and develops pain therapeutics targeted on neuronal nitric oxide synthase.

BiotechnologyNeuroscienceTherapeutics
Debt FinancingSep 30, 2010
Amount Raised: $14,000,000
NeurAxon

Toronto, Ontario, Canada

NeurAxon discovers and develops pain therapeutics targeted on neuronal nitric oxide synthase.

BiotechnologyNeuroscienceTherapeutics
Series BAug 20, 2007
Amount Raised: $32,000,000